Sánchez V, Goberna R, Calvo J R
Department of Medical Biochemistry and Molecular Biology, Medical School, University of Sevilla, Spain.
Experientia. 1991 Jun 15;47(6):625-6. doi: 10.1007/BF01949891.
The effects of VIP (300 pmol/kg), injected via the portal vein, on the glycogen content of the liver and on glycemia, were studied in the rat in vivo. VIP enhanced glycogenolysis and caused hyperglycemia in a time-dependent manner.